Wonpyo Yun

Principal @ Aisling Capital

About

Biotechnology Venture Capital at Aisling Capital

Country

United States

City

New York

Industry

Venture Capital & Private Equity

Skill

Financial Modeling, Bloomberg, Investment Banking, Capital IQ, Valuation, Financial Analysis, Economics, Corporate Finance, PowerPoint

Experience

Principal

Aisling Capital

2022-7 - Present · 4 yrs 3 mos

New York, NY

Biotechnology and life sciences VC building and investing in innovative therapeutics, healthcare products, services and technologies.

Investments

BridgeBio

2021-7 - 2022-6 · 1 yr

New York, New York, United States

M&A, BD, Investments

BridgeBio

2020-6 - 2021-6 · 1 yr 1 mo

Palo Alto, CA

Analyst

Aisling Capital

2016-7 - 2019-4 · 2 yrs 10 mos

New York, New York, United States

Investment Banking Analyst

Credit Suisse

2014-8 - 2016-7 · 2 yrs

New York, New York, United States

Investment Banking Analyst

RBC Capital Markets

2013-7 - 2014-8 · 1 yr 2 mos

New York, New York, United States

Education

Stanford University Graduate School of Business

2019 - 2021 · 2 yrs

TA, GSBGEN 597: Growth in the Developing Countries, Emerging Economies and the Global Economy (Profs. David Brady & Michael Spence) Investor, The 21 Fund: $2M seed fund building and investing in GSB '21 founders and startups

Princeton University

Molecular Biology

2009 - 2013 · 4 yrs

Magna cum laude, Sigma Xi Senior Thesis (Lab) | Advisor: Mark Rose, PhD • Regulation of karyogamy protein Kar4p during mitosis and mating in Saccharomyces cerevisiae • Awarded Senior Thesis Prize; Inducted into Sigma Xi Society Finance Certificate | Independent Work • PrEP-ping for HIV: Pre-exposure prophylaxis (Truvada) as a cost-effective method for public health